Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.

Pan HC, Lai DW, Lan KH, Shen CC, Wu SM, Chiu CS, Wang KB, Sheu ML.

Carcinogenesis. 2013 Nov;34(11):2568-79. doi: 10.1093/carcin/bgt243. Epub 2013 Jul 4.

PMID:
23828905
2.

Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.

Liu SH, Lee WJ, Lai DW, Wu SM, Liu CY, Tien HR, Chiu CS, Peng YC, Jan YJ, Chao TH, Pan HC, Sheu ML.

Mol Oncol. 2015 Apr;9(4):834-49. doi: 10.1016/j.molonc.2014.12.009. Epub 2015 Jan 6.

3.

The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination.

Lai DW, Liu SH, Karlsson AI, Lee WJ, Wang KB, Chen YC, Shen CC, Wu SM, Liu CY, Tien HR, Peng YC, Jan YJ, Chao TH, Lan KH, Arbiser JL, Sheu ML.

Oncotarget. 2014 Sep 15;5(17):7788-804.

4.

Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.

Liu SH, Wang KB, Lan KH, Lee WJ, Pan HC, Wu SM, Peng YC, Chen YC, Shen CC, Cheng HC, Liao KK, Sheu ML.

PLoS One. 2012;7(8):e43711. doi: 10.1371/journal.pone.0043711. Epub 2012 Aug 24.

5.

Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.

Lee WJ, Lan KH, Chou CT, Yi YC, Chen WC, Pan HC, Peng YC, Wang KB, Chen YC, Chao TH, Tien HR, Sheu WH, Sheu ML.

Neoplasia. 2013 Sep;15(9):1036-48.

7.

Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.

Boreddy SR, Srivastava SK.

Oncogene. 2013 Aug 22;32(34):3980-91. doi: 10.1038/onc.2012.413. Epub 2012 Sep 17.

8.

HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.

Miyake S, Kitajima Y, Nakamura J, Kai K, Yanagihara K, Tanaka T, Hiraki M, Miyazaki K, Noshiro H.

Int J Oncol. 2013 Nov;43(5):1431-40. doi: 10.3892/ijo.2013.2068. Epub 2013 Aug 21.

PMID:
23970191
9.

Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.

Kim G, Khanal P, Lim SC, Yun HJ, Ahn SG, Ki SH, Choi HS.

Carcinogenesis. 2013 Feb;34(2):341-50. doi: 10.1093/carcin/bgs342. Epub 2012 Nov 3.

PMID:
23125217
10.

Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.

Liu SH, Shen CC, Yi YC, Tsai JJ, Wang CC, Chueh JT, Lin KL, Lee TC, Pan HC, Sheu ML.

Br J Pharmacol. 2010 Aug;160(8):1963-72. doi: 10.1111/j.1476-5381.2010.00804.x.

11.

Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain-mediated C/EBPβ and NFκB cleavage.

Wu SM, Lin WY, Shen CC, Pan HC, Keh-Bin W, Chen YC, Jan YJ, Lai DW, Tang SC, Tien HR, Chiu CS, Tsai TC, Lai YL, Sheu ML.

J Pineal Res. 2016 Mar;60(2):142-54. doi: 10.1111/jpi.12295. Epub 2015 Dec 16.

PMID:
26514342
12.

Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.

Kurashige J, Mima K, Sawada G, Takahashi Y, Eguchi H, Sugimachi K, Mori M, Yanagihara K, Yashiro M, Hirakawa K, Baba H, Mimori K.

Carcinogenesis. 2015 Jan;36(1):133-41. doi: 10.1093/carcin/bgu232. Epub 2014 Nov 19.

PMID:
25411357
13.

u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer.

Ding Y, Zhang H, Zhou Z, Zhong M, Chen Q, Wang X, Zhu Z.

World J Surg Oncol. 2012 Dec 12;10:270. doi: 10.1186/1477-7819-10-270.

14.

Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer.

Okugawa Y, Inoue Y, Tanaka K, Kawamura M, Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y, Kusunoki M.

Clin Exp Metastasis. 2013 Apr;30(4):417-29. doi: 10.1007/s10585-012-9547-4. Epub 2012 Nov 11.

PMID:
23143680
15.

Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.

Hahm ER, Arlotti JA, Marynowski SW, Singh SV.

Clin Cancer Res. 2008 Feb 15;14(4):1248-57. doi: 10.1158/1078-0432.CCR-07-1926.

16.

Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.

Hong SM, Park CW, Cha HJ, Kwon JH, Yun YS, Lee NG, Kim DG, Nam HG, Choi KY.

Clin Exp Metastasis. 2013 Feb;30(2):177-87. doi: 10.1007/s10585-012-9526-9. Epub 2012 Aug 9.

PMID:
22875246
17.

Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.

Chen YJ, Wu CL, Liu JF, Fong YC, Hsu SF, Li TM, Su YC, Liu SH, Tang CH.

Cancer Lett. 2010 May 1;291(1):20-30. doi: 10.1016/j.canlet.2009.08.032. Epub 2009 Oct 31.

PMID:
19880244
18.

AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.

Shi Z, Zhang J, Qian X, Han L, Zhang K, Chen L, Liu J, Ren Y, Yang M, Zhang A, Pu P, Kang C.

Cancer Res. 2013 Sep 1;73(17):5519-31. doi: 10.1158/0008-5472.CAN-13-0280. Epub 2013 Jun 28.

19.

Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.

Chen DH, Yu JW, Wu JG, Wang SL, Jiang BJ.

J Cancer Res Clin Oncol. 2015 Dec;141(12):2109-20. doi: 10.1007/s00432-015-1973-7. Epub 2015 May 8.

20.

Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.

Suman S, Kurisetty V, Das TP, Vadodkar A, Ramos G, Lakshmanaswamy R, Damodaran C.

Mol Carcinog. 2014 Feb;53 Suppl 1:E151-60. doi: 10.1002/mc.22076. Epub 2013 Sep 2.

PMID:
24000138

Supplemental Content

Support Center